Page last updated: 2024-08-25

anaxirone and Neoplasm Metastasis

anaxirone has been researched along with Neoplasm Metastasis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clavel, M; Decoster, G; Holdener, EE; Klepp, O; Ludwig, C; Pinedo, HM; Renard, G; Sessa, C; Siegenthaler, P; ten Bokkel Huinink, W1
Bremer, K; Donhujsen-Ant, R; Peukert, M; Possinger, K; Queisser, W; Wagner, H1

Trials

1 trial(s) available for anaxirone and Neoplasm Metastasis

ArticleYear
Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) study.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Thrombocytopenia; Treatment Outcome; Triazoles

1994

Other Studies

1 other study(ies) available for anaxirone and Neoplasm Metastasis

ArticleYear
Phase II trial of 1,2,4-triglycidylurazol in patients with metastasized renal cell carcinoma.
    Cancer treatment reports, 1987, Volume: 71, Issue:2

    Topics: Adult; Aged; Carcinoma, Renal Cell; Drug Evaluation; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Triazoles

1987